MedPath

A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults

Phase 1
Completed
Conditions
Healthy subject
Registration Number
JPRN-jRCT2080224786
Lead Sponsor
Kyowa Kirin Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
Male
Target Recruitment
64
Inclusion Criteria

1) Written voluntary informed consent to participate in the study;
2)
[Food Effect Part] Japanese men 20 to <40 years of age at informed consent;
[Caucasian Subject Part] Caucasian men 20 to <40 years of age at informed consent;
3) BMI 18.5 kg/m2 to <25.0 kg/m2 at screening

Exclusion Criteria

1) Presence of any disease requiring treatment;
2) History of heart failure (e.g., history of diagnosis of congestive heart failure categorized as Class III or IV of the New York Heart Association (NYHA) Functional Classification or history of hospitalization due to heart failure);
3) Alcoholism or drug addiction, or any positive result on drug abuse testing;
4) History of or current drug allergy;
5) Any positive result on infectious disease testing.;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
pharmacokinetics<br>Cmax, AUC0-t
Secondary Outcome Measures
NameTimeMethod
pharmacokinetics<br>tmax, AUC0-inf, t1/2, MRT, kel
© Copyright 2025. All Rights Reserved by MedPath